Eben Tessari insider trades: Kiniksa Pharmaceuticals International (KNSA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Eben reports to the SEC
Open-market buys and sales
24 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | KNSA | ↓ Sell | 12,048 | $41.56 | $501K | Direct | Dec 17, 2025 (2d) |
| Nov 26, 2025 | KNSA | ↓ Sell | 200 | $42.89 | $9K | Direct | Dec 1, 2025 (5d) |
| Nov 17, 2025 | KNSA | ↓ Sell | 12,470 | $41.24 | $514K | Direct | Nov 19, 2025 (2d) |
| Oct 14, 2025 | KNSA | ↓ Sell | 12,368 | $37.67 | $466K | Direct | Oct 16, 2025 (2d) |
| Sep 29, 2025 | KNSA | ↓ Sell | 42,000 | $38.33 | $1.6M | Direct | Oct 1, 2025 (2d) |
| Sep 15, 2025 | KNSA | ↓ Sell | 16,400 | $36.46 | $598K | Direct | Sep 17, 2025 (2d) |
| Sep 5, 2025 | KNSA | ↓ Sell | 98,660 | $35.54 | $3.5M | Direct | Sep 8, 2025 (3d) |
| Sep 3, 2025 | KNSA | ↓ Sell | 15,091 | $35.50 | $536K | Direct | Sep 3, 2025 (0d) |
| Aug 18, 2025 | KNSA | ↓ Sell | 16,200 | $33.77 | $547K | Direct | Aug 20, 2025 (2d) |
| Aug 5, 2025 | KNSA | ↓ Sell | 138,614 | $33.20 | $4.6M | Direct | Aug 7, 2025 (2d) |
| Jul 14, 2025 | KNSA | ↓ Sell | 18,900 | $28.72 | $543K | Direct | Jul 16, 2025 (2d) |
| Jun 16, 2025 | KNSA | ↓ Sell | 17,300 | $28.28 | $489K | Direct | Jun 18, 2025 (2d) |
| Jun 11, 2025 | KNSA | ↓ Sell | 70,867 | $30.48 | $2.2M | Direct | Jun 11, 2025 (0d) |
| May 19, 2025 | KNSA | ↓ Sell | 12,000 | $26.41 | $317K | Direct | May 21, 2025 (2d) |
| Apr 14, 2025 | KNSA | ↓ Sell | 12,000 | $20.48 | $246K | Direct | Apr 16, 2025 (2d) |
| Mar 10, 2025 | KNSA | ↓ Sell | 12,409 | $21.06 | $261K | Direct | Mar 12, 2025 (2d) |
| Feb 10, 2025 | KNSA | ↓ Sell | 14,000 | $19.57 | $274K | Direct | Feb 12, 2025 (2d) |
| Jan 13, 2025 | KNSA | ↓ Sell | 14,000 | $18.24 | $255K | Direct | Jan 15, 2025 (2d) |
| Dec 16, 2024 | KNSA | ↓ Sell | 23,017 | $20.44 | $470K | Direct | Dec 18, 2024 (2d) |
| Nov 18, 2024 | KNSA | ↓ Sell | 17,000 | $21.04 | $358K | Direct | Nov 20, 2024 (2d) |
| Oct 15, 2024 | KNSA | ↓ Sell | 17,000 | $26.87 | $457K | Direct | Oct 17, 2024 (2d) |
| Sep 23, 2024 | KNSA | ↓ Sell | 17,500 | $24.99 | $437K | Direct | Sep 25, 2024 (2d) |
| Aug 27, 2024 | KNSA | ↓ Sell | 17,500 | $26.91 | $471K | Direct | Aug 29, 2024 (2d) |
| Mar 1, 2024 | KNSA | ↓ Sell | 1,189 | $22.03 | $26K | Direct | Mar 5, 2024 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KNSA insiders
Open-market trades in the last 12 months
About Eben Tessari's insider trades
Eben Tessari is Chief Strategy Officer at Kiniksa Pharmaceuticals International (KNSA). Since Mar 1, 2024, Eben has reported no open-market purchases and 24 sales worth $19.7M on SEC Form 4. In the last 12 months: 3 sales ($1.0M).
Their filings also include option exercises (38 filings), shares withheld for taxes (15 filings), grants and awards (13 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KNSA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.